FDA June 2019 PMTA Guidance Deadline for Submission
In June of 2019, the FDA issued its final guidance on the Premarket Tobacco Application (PMTA) which detailed that e-cigarette, e-liquid, and vaping manufacturers need to submit their PMTA by August 2021.
E-liquid manufacturers, along with their partners in the testing space, including analytical laboratories, toxicology and clinical partners, and attorneys and consultants, were under the impression they had just 2 years to start and complete their PMTA submission to the FDA.
However, submission deadline has recently been shortened to May of 2020.
Why was the PMTA Submission Deadline Moved Up to May 2020?
Back in March of 2018, a group of plaintiffs including the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, American Academy of Pediatrics, Truth Initiative, and the Campaign for Tobacco-Free Kids filed a lawsuit against the FDA for delaying the commencement of the PMTA.
On July 11, 2019, the Maryland District Court made its final decision that PMTAs for products already on the market are due in just 10 short months (May 2020) with a 1 year marketing exemption period for new products.
As of July 11, 2019, the FDA has 30 days to appeal this decision, and there is some speculation that the FDA will not appeal this decision. If the 30 day window passes, May 2020 will remain the date for PMTA submissions.
How Can Avomeen Help You Meet the Accelerated Timeline for FDA PMTA Submission?
Avomeen is an independent e-liquid, e-cigarette, and vape testing lab proudly serving entrepreneurs, manufacturers, distributors, lawyers, other laboratories, and companies of all sizes. We are an FDA-registered lab with years of experience working on successful FDA regulatory submissions. Our team of regulatory and industry experts are experienced with new testing standards pertaining to the e-liquids/e-cigarettes and the FDA’s Premarket Tobacco Application (PMTA) requirements.
We customize our approach for every customer we serve and offer full support for your projects. Our regulatory consultants can aid your team in their efforts to gain FDA approval, both during and after a project is completed. Get in touch with us to discuss your project.
Is finding the right lab to partner with stressing you out? Our blog, Choosing the Right Lab for PMTA Compliance, offers some guidance.
Want to know more about the new PMTA guidelines? Check out our blog, What You Need to Know About the FDA’s New PMTA Guidance.
We’ve outlined the major similarities and differences between the 2016 and 2019 PMTA guidance in our blog, Overview of Premarket Tobacco Application (PMTA) FDA Guidance for ENDS.
An Extractables & Leachables (E&L) study is now required for e-cigarette, e-liquid and vaping products. If you’re not familiar with E&L studies, take a look at our blog, E-Liquids Extractables and Leachables Testing for the PMTA.
The 9 most commonly asked questions about PMTA requirements are answered in our blog, 2019 FDA PMTA Guidance FAQs.
FDA is actively enforcing PMTA guidance. Check out our blog, FDA Issues Warning Letters for E-Liquid Products without Marketing Authorization, for more details.
Our expert blogger is Dr. Derek Beachamp, Avomeen’s Senior Technical Director of Analytical Sciences. His knowledge of the PMTA and nicotine testing have been showcased in vape industry publications including Smoke and Vape Business Solutions and Vapor Voice.
Learn more about Derek’s expertise and experience.